Adlai Nortye Future Growth
Future criteria checks 0/6
Adlai Nortye is forecast to grow revenue at 71.7% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 71.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 09 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 56 | N/A | -39 | -31 | 1 |
| 12/31/2025 | N/A | N/A | -119 | -49 | 1 |
| 12/31/2024 | N/A | N/A | N/A | -52 | 1 |
| 6/30/2024 | 5 | -54 | -67 | -67 | N/A |
| 3/31/2024 | 5 | -104 | -61 | -61 | N/A |
| 12/31/2023 | 5 | -105 | -57 | -57 | N/A |
| 9/30/2023 | 3 | -114 | -48 | -47 | N/A |
| 6/30/2023 | N/A | -123 | -39 | -38 | N/A |
| 3/31/2023 | N/A | -63 | -42 | -41 | N/A |
| 12/31/2022 | N/A | -59 | -44 | -43 | N/A |
| 12/31/2021 | 46 | -57 | -4 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if N2U0's forecast earnings growth is above the savings rate (0.8%).
Earnings vs Market: Insufficient data to determine if N2U0's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if N2U0's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: N2U0 is forecast to have no revenue next year.
High Growth Revenue: N2U0 is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if N2U0's Return on Equity is forecast to be high in 3 years time